CN113425650A - 一种含植物活性成分的控油组合物 - Google Patents
一种含植物活性成分的控油组合物 Download PDFInfo
- Publication number
- CN113425650A CN113425650A CN202110940452.8A CN202110940452A CN113425650A CN 113425650 A CN113425650 A CN 113425650A CN 202110940452 A CN202110940452 A CN 202110940452A CN 113425650 A CN113425650 A CN 113425650A
- Authority
- CN
- China
- Prior art keywords
- oil
- control composition
- oil control
- extract
- rosa canina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 239000004480 active ingredient Substances 0.000 title claims abstract description 12
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 240000008530 Rosa canina Species 0.000 claims abstract description 37
- 235000000539 Rosa canina Nutrition 0.000 claims abstract description 37
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 25
- 108010077895 Sarcosine Proteins 0.000 claims abstract description 21
- 229940043230 sarcosine Drugs 0.000 claims abstract description 21
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 19
- 210000001732 sebaceous gland Anatomy 0.000 claims abstract description 19
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims abstract description 15
- 230000004069 differentiation Effects 0.000 claims abstract description 10
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 claims abstract description 9
- 241000218211 Maclura Species 0.000 claims abstract description 3
- 240000003664 Maclura cochinchinensis Species 0.000 claims description 15
- 239000004615 ingredient Substances 0.000 claims description 11
- 241000933832 Broussonetia Species 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 abstract description 20
- 230000028327 secretion Effects 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004027 cell Anatomy 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 229940073140 rosa canina fruit extract Drugs 0.000 abstract description 6
- 230000001276 controlling effect Effects 0.000 abstract description 4
- 240000006248 Broussonetia kazinoki Species 0.000 abstract description 3
- 210000004378 sebocyte Anatomy 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 67
- 235000019198 oils Nutrition 0.000 description 67
- 239000000839 emulsion Substances 0.000 description 29
- 238000012360 testing method Methods 0.000 description 14
- 239000000843 powder Substances 0.000 description 12
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000004519 grease Substances 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 5
- 239000003098 androgen Substances 0.000 description 5
- -1 polysaccharide compound Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229960003604 testosterone Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 229940093797 bioflavonoids Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- 240000007817 Olea europaea Species 0.000 description 3
- CZWCKYRVOZZJNM-UHFFFAOYSA-N Prasterone sodium sulfate Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 CZWCKYRVOZZJNM-UHFFFAOYSA-N 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 229940030486 androgens Drugs 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229950009829 prasterone sulfate Drugs 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004965 Silica aerogel Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- IZLSVSOPNPRBNS-UHFFFAOYSA-K 4-O-bis[(4-octoxy-4-oxobutanoyl)oxy]alumanyl 1-O-octyl butanedioate Chemical compound [Al+3].CCCCCCCCOC(=O)CCC([O-])=O.CCCCCCCCOC(=O)CCC([O-])=O.CCCCCCCCOC(=O)CCC([O-])=O IZLSVSOPNPRBNS-UHFFFAOYSA-K 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 1
- 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
- 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 241000124793 Orlaya grandiflora Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000009134 Steryl-Sulfatase Human genes 0.000 description 1
- 108010087999 Steryl-Sulfatase Proteins 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- QFSKIUZTIHBWFR-UHFFFAOYSA-N chromium;hydrate Chemical compound O.[Cr] QFSKIUZTIHBWFR-UHFFFAOYSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- SZPIKCAXBLKNNK-UHFFFAOYSA-N dimethyl-phenoxy-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C)OC1=CC=CC=C1 SZPIKCAXBLKNNK-UHFFFAOYSA-N 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种含植物活性成分的控油组合物,该控油组合物包含抑制5α‑还原酶的成分,其中,所采用的抑制5α‑还原酶的成分包括生物类黄酮,该生物类黄酮优选为植物构棘(Maclura cochinchinensis)叶提取物。本发明的控油组合物进一步包含抑制皮脂腺细胞分化的狗牙蔷薇(Rosa canina L.)果提取物。本发明将生物类黄酮、狗牙蔷薇果提取物、肌氨酸组合形成控油方案,从抑制5a‑还原酶、抑制皮脂腺分化两个靶点进行调节皮脂分泌,同时舒缓肌肤,降低皮肤压力来降低皮脂细胞活跃度从而达到更高效的控油目的。
Description
技术领域
本发明涉及一种皮肤控油组合物,更具体地讲,本发明涉及一种含植物活性成分的、但不含矿物成分、不含粉末的控油组合物。
背景技术
皮脂的主要成分有甘油三酯、蜡酯、角鲨烯、半乳糖、维生素E、抗菌肽,它具有保护和滋润皮肤的作用。皮脂分泌过少,会导致皮肤干燥敏感;皮脂分泌过旺,也就是油性肌肤,会导致如面部有油光、长痘、毛孔粗大、肤色暗沉等肌肤问题。因此,控制油脂分泌,维持皮肤皮脂平衡,有助于保持皮肤的美观和健康。
皮脂分泌除了受雄性激素影响,还受皮脂腺数量、细胞数量、温湿度、压力等影响,因此,通过抑制皮脂腺细胞分化和功能、降低皮肤温度,可辅助控制皮脂分泌。
目前,现有的化妆品中,为了控制或调节皮脂分泌,主要是采用一些吸油粉末成分,例如二氧化硅、聚甲基丙烯酸甲酯、尼龙粉末、氮化硼粉末、滑石、二氧化钛、氧化锌、硅弹体等。
例如,中国专利201611167727.4公开了一种控油爽肤水及其制备方法。以控油爽肤水的总重量计,该控油爽肤水包括以下组分:二氧化硅微球体:0.1-5%,优选为1-3%;保湿剂:3-15%,优选为6-10%;多糖类化合物:0.5-8%,优选为1-5%;蒙脱土:0.1-5%,优选为0.5-3%;水:75-93%,优选为80-90%。该专利是通过二氧化硅微球体来吸收皮脂的。
中国专利201610752031.1公开了一种具有控油功效的护肤品及其制备方法,该护肤品包括如下质量份的各组分:控油组合物0.2~12份、C12~15醇苯甲酸酯2.0~8.0份、环五聚二甲基硅氧烷20.6~52.6份、生育酚乙酸酯0.1~0.5份、二硬脂二甲铵锂蒙脱石0.2~0.8份、辛基聚甲基硅氧烷1.0~5.0份、二苯基聚二甲基硅氧烷5.0~20.0份;其中,所述控油组合物包括在护肤品中所占质量份如下的各组分:蜂王浆控油因子0.2~1.0份、二氧化硅1.0~5.0份、甲基丙烯酸甲酯1.0~3.0份、辛基琥珀酸铝淀粉1.0~3.0份。该专利认为其产品控油效果佳、使用感觉好、使用过程中不会出现搓泥现象等。
中国专利201610738892.4公开了一种控油去黑头功效的水凝胶面膜,该面貌包括有面膜基质和背衬层,面膜基质是由按照重量份计的如下组分所制成:仙人球肉提取物、蓝桉提取物、茶树精油、柠檬精油、罗勒精油、洋甘菊提取物、阿魏酸、氮酮、甘油、芦荟提取液、聚氧乙烯失水山梨醇月桂酸酯、珍珠粉、羧甲基纤维素钠、甲基纤维素、交联聚维酮、氯化钠、维生素E、防腐剂、香精、水。该专利声称其面膜具有去黑头、控油、保湿的功效。
中国专利201580067895.3公开了一种施用至皮肤的基于粉末的化妆品组合物,该组合物包含:(a)一种或多种化妆品可接受的颗粒物,其为天然疏水性的或涂覆有疏水性材料;(b)至少一种用于所述基于粉末的化妆品组合物的颗粒物的粘合剂;和(c)对由皮肤分泌的皮脂具有亲合性的成膜吸油聚合物。其中,成膜吸油聚合物具有极性区域和非极性区域,并在与皮肤所分泌的皮脂接触时该聚合物将皮脂分解成单个的液滴并将其截留在膜中。吸油聚合物可以是具有含亲脂侧链的蛋白质主链的杂聚物,例如C2-C16酰化乳球蛋白或C2-C16酰化植物蛋白。该专利的颗粒物选自有机颜料、无机颜料、填料及其混合物,无机颜料则选自二氧化钛、氧化锆、氧化铈、氧化锌、铁氧化物、氧化铬、绢云母、云母、滑石、高岭土、锰紫、群青蓝、铬水合物、铁蓝、金属粉末及其混合物。
欧莱雅公司的中国专利201180062264.4公开了一种化妆品组合物,其包含如下成分的混合物:比表面积为500至1500m2/g且以体积-平均直径(D[0.5])表示的尺寸为1到1500μm的疏水二氧化硅气凝胶颗粒、粘度小于10mm2/s的至少一种第一线性硅油、和粘度大于或等于10mm2/s的至少一种第二线性硅油。该专利认为,二氧化硅气凝胶颗粒与线性硅油的混合物可使获得的组合物施用舒适柔软,并具有控油和柔光性质。
中国专利200910213707.X公开了一种控油化妆品组合物,按重量百分比计算,该组合物包含以下组分:0.01~10%的水溶性锌盐、0.1~8%的吸油粉末、0.1~15%的蜂王浆提取物、0.1~20%的天然中草药提取物、0.32~47%的化妆品基质、余量为去离子水。该专利通过添加吸油粉末来吸收皮肤油脂。
现有技术的这些控油成分是来自合成成分或矿物成分,除了吸收皮脂的能力外,难以具有进一步的功效。
为了能够有效地在根源上进行控油,有必要针对皮脂分泌相关各靶点进行调节。
发明内容
本发明的发明目的就是要提供一种不通过矿物成分或其它吸油粉末进行控油的控油组合物,以克服现有技术的不足,提供更高效的皮肤控油解决方案。
为实现上述的发明目的,本发明提供了一种含植物活性成分的控油组合物,该控油组合物包含基础液和抑制5α-还原酶的成分,其中,抑制5α-还原酶的成分包括生物类黄酮。优选地,本发明的控油组合物不含矿物成分和粉末等传统的吸油物质。
在上述本发明的控油组合物中,之所以含有抑制5α-还原酶的成分,是因为考虑到:皮脂腺功能主要受内分泌系统的调节,而雄激素(睾酮和DHT)是影响皮脂分泌的首要因素,它调节皮脂腺的分化、增殖及皮脂的合成与分泌。皮脂腺中含有从胆固醇转换为类固醇、皮质激素前体物质——硫酸脱氢表雄酮(DHEAS)与脱氢表雄酮(DHEA)所需的所有酶类,能够直接利用胆固醇合成雄激素,也能够把低活性的雄性激素转化为高活性激素。DHEAS通过皮肤中广泛分布的类固醇硫酸酯酶转化DHEA,后者通过位于皮脂腺的羟基类固醇脱氢酶系代谢为雄二酮和睾酮,睾酮经5α-还原酶转化为活性更强的5α-二氢睾酮(DHT)。睾酮和DHT是有活性的雄性激素,后者的作用强度是前者的5-10倍。因此,本发明的控油组合物中,针对5α-还原酶进行抑制,为调节皮肤油脂分泌开辟新的途径。
优选地,在本发明的控油组合物中,所采用的生物类黄酮为植物构棘(Macluracochinchinensis)叶提取物。
构棘(学名:Maclura cochinchinensis(Loureiro)Corner)是桑科、柘属直立或攀援状灌木;枝无毛,具粗壮弯曲无叶的腋生刺,叶革质,叶片椭圆状披针形或长圆形,全缘,先端钝或短渐尖,基部楔形,两面无毛。构棘分布于中国东南部至西南部的亚热带地区,斯里兰卡、印度、尼泊尔、不丹、缅甸、越南、中南半岛各国、马来西亚、菲律宾、日本、澳大利亚、新喀里多尼亚也有分布。构棘叶中富含生物类黄酮,从构棘叶中提取的生物类黄酮能从调节皮肤油脂分泌、减少肌肤炎症、调整肌肤微生态等多方面来调节皮肤油脂,助力肌肤健康。
本发明的发明人发现,生物类黄酮调节皮肤油脂分泌的机理主要是抑制5a-还原酶将睾酮还原生成高活性5α-二氢睾酮(DHT)。
优选地,在本发明的控油组合物中,以重量百分比计,构棘(Macluracochinchinensis)叶提取物占控油组合物总重量的0.1-10%,更优选为0.3-3%,例如0.5-2%。
在本发明中,除了采用抑制5a-还原酶的成分、以降低将睾酮还原生成高活性5α-二氢睾酮(DHT)之外,本发明还采用抑制皮脂腺细胞分化的成分,以降低皮脂分泌的速度。
优选地,在本发明的控油组合物中,所述的抑制皮脂腺细胞分化的成分为狗牙蔷薇(Rosa canina L.)果提取物。
狗牙蔷薇(Rosa canina L.)也称犬蔷薇,是双子叶植物纲、蔷薇属植物,属于灌木植物,单生或簇生,枝茎呈弓形或者是蔓生;花两性,有5片花瓣,并有雄性花蕊;花朵有一股甜甜的清香,颜色从白到深粉红色都有;花期从早春持续到秋末;果期9-10月,果实近球形,直径6-8厘米,红褐色或紫褐色,有光泽,形如橄榄,熟透的果实红艳似玛瑙,晶莹润泽。
狗牙蔷薇广泛分布于世界各地的温带地区,喜生长在乡村和1500米的山丘上。狗牙蔷薇果是制作果酱、糖浆、茶和甜酒的主要原料,小叶用于外敷可治疗创伤,果实含丰富维他命C,是世界上应用最广的两大果用蔷薇之一。
本发明的发明人发现,狗牙蔷薇果提取物中富含的黄酮类活性成分,具有抑制皮脂腺细胞分化的作用,从而降低皮脂分泌的速度。皮脂腺细胞在分化过程中持续合成和积累皮脂,成熟后皮脂腺细胞退化溶解,并释放油脂到皮肤表面。因而,抑制皮脂腺细胞分化,能有效地减少皮肤皮脂分泌速度。
优选地,在本发明的控油组合物中,以重量百分比计,狗牙蔷薇(Rosa canina L.)果提取物占控油组合物总重量的0.1-5%,更优选为0.2-2%,例如0.3-0.8%。
进一步地,在本发明的控油组合物中,还可以进一步含有肌氨酸。
肌氨酸通常是一种合成的物质,化学式为C3H7NO2,白色正交结晶,微有甜味,具潮解性,能溶于水,微溶于醇,不溶于醚,存在于海星和海胆中。
肌氨酸可以提高人的智力,补充肌氨酸可以增长肌肉无氧力量和爆发力,有效地改善运动表现、力量、恢复时间及纯瘦。但本发明的发明人发现,肌氨酸同样具有抑制Ⅰ型5α-还原酶的作用。
优选地,在本发明的控油组合物中,以重量百分比计,肌氨酸占控油组合物总重量的0.01-1%,更优选为0.02-0.2%,例如0.03-0.1%。
在本发明的一具体实施方式中,本发明的控油组合物所含有的构棘(Macluracochinchinensis)叶提取物、狗牙蔷薇(Rosa canina L.)果提取物和肌氨酸分别占控油组合物总重量的0.1-10%、0.1-5%和0.02-1%。
在本发明的另一具体实施方式中,本发明的控油组合物所含有的构棘(Macluracochinchinensis)叶提取物、狗牙蔷薇(Rosa canina L.)果提取物和肌氨酸分别占控油组合物总重量的0.3-3%、0.2-2%和0.02-0.2%。
在本发明的控油组合物中,所采用的基础液可以是常规的化妆品常用的基础乳液,例如修护乳。为了使本发明的抑制5a-还原酶的成分和抑制皮脂腺细胞分化的成分更好地发挥作用,在本发明的基础乳液中优选包含如下组分:保湿剂、增稠剂、油脂、乳化剂和防腐剂。
上述基础乳液中所采用的保湿剂可以为如下一组多元醇中的一种或一种以上:甘油、1,3-丙二醇、二丙二醇、1,3-丁二醇、甘油、透明质酸(钠)等;
上述基础乳液中所采用的增稠剂可以为如下一组物质中的一种或一种以上:黄原胶、卡拉胶、聚丙烯酸钠、各种卡波(carbopol)如carbopol 940、carbopol 941、carbopoletd 2020(丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联共聚物)、carbopol aqua sf-1、carbopolultrez 20、carbopol ultrez 21、pemulen tr-1、pemulen tr-2等;
上述基础乳液中所采用的油脂可以为如下一组物质中的一种或一种以上:辛酸/葵酸甘油三酯、甜扁桃油、聚二甲基硅氧烷KF-96A-6T、C10-18脂酸甘油三酯类、角鲨烷、碳酸二辛酯、异壬酸异壬酯、十六十八醇、鲸蜡醇、精制冷榨乳木果油等;这些油脂主要起柔润、滋润、湿润、抗氧化、抗衰老、润肤、防干躁等作用;
上述基础乳液中所采用的乳化剂可以为如下一组物质中的一种或一种以上:氢化卵磷脂、鲸蜡醇磷酸酯钾、硬脂酰谷氨酸钠、鲸蜡硬脂醇橄榄油酸酯/山梨坦橄榄油酸酯、聚二甲基硅氧烷/聚二甲基硅氧烷PEG-10/15交联聚合物等;
上述基础乳液中所采用的防腐剂可以为如下一组物质中的一种或一种以上:苯氧乙醇、对羟基苯乙酮、乙基己基甘油、1,2-己二醇、氯苯甘醚、辛甘醇/辛酰羟肟酸等。
值得注意的是,在上述基础乳液中,许多组分可以同时起多种作用,例如有的物质可以同时起保湿剂、增稠剂、油脂、乳化剂、防腐剂中的一种以上的作用。
当然,基础乳液中还可以含有其它的功能组分。
本发明将生物类黄酮、狗牙蔷薇果提取物、肌氨酸组合形成控油方案,从抑制5a-还原酶、抑制皮脂腺分化两个靶点进行调节皮脂分泌,同时舒缓肌肤,降低皮肤压力来降低皮脂细胞活跃度从而达到更高效的控油目的。
为了使本发明目的、技术方案及优点更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。
附图说明
图1是在面部涂抹根据本发明一实施方式制备的控油乳A28天前后的皮肤油脂含量;
图2是在面部涂抹根据本发明另一实施方式制备的控油乳B28天前后的皮肤油脂含量;
图3是涂抹控油乳A28天后与涂抹控油乳B28天后的皮肤油脂含量变化率对比;
图中,D0表示涂抹前,D28表示涂抹28天后。
具体实施方式
实施例1
本实施例首先按照表1的配方配制了控油修护乳的基础乳液(以下简称基础乳液);
在基础乳液的配方基础上,加入1%的生物类黄酮,形成含植物活性成分的控油组合物-控油修护乳A(简称控油乳A);所用的生物类黄酮是瑞士RAHN AG生产的、商品名为SEBOCLEAR-MPs的植物构棘(Maclura cochinchinensis)叶提取物;控油乳A的配方见表2;
在基础乳液的配方基础上,加入1%的生物类黄酮、狗牙蔷薇(Rosa canina L.)果提取物0.5%、肌氨酸0.04%,形成含植物活性成分的控油组合物-控油修护乳B(简称控油乳B);其中,所用的生物类黄酮是瑞士RAHN AG生产的、商品名为SEBOCLEAR-MPs的植物构棘(Maclura cochinchinensis)叶提取物,狗牙蔷薇(Rosa canina L.)果提取物是法国Silab生产的、商品名为Sebocytine的产品;控油乳B的配方见表3;
试验效果的验证
功效试验方案:
测试志愿者人数:20人
测试方法:志愿者每天在面部涂抹两次控油乳液,共28天,测试前用清水洗脸,静坐30分钟后测试。
测试指标:皮肤油脂含量
实验组:
控油乳A:基础乳液+1%生物类黄酮
控油乳B:基础乳液+1%生物类黄酮+0.04%肌氨酸+0.5%狗牙蔷薇果提取物
测试仪器:皮肤油脂测试仪Sebumeter SM815(Courage&Khazaka,德国)
参数解释:参数值越小,说明皮肤油脂含量越低;
油脂变化率:(D28-D0)/D0*100%
受试者测试当天到达实验室,用洁面乳清洁面部,清洗完后用干的面巾纸擦拭干净。受试者在恒温恒湿间休息30min后进行仪器测试,使用Sebumeter SM815连续测试3次取平均值,采集志愿者皮肤的测试指标初始值。
测试完成后对受试者进行产品使用说明,受试者听取说明后,发放产品,受试者按照要求使用试验样品,28天后进行仪器测试,测试方法同初始值测试方法。
结果判定:产品使用后,测试区域皮肤油脂含量呈显著性降低,表示测试样品具有控油效果。
实验结论:结合图-图3,可以发现:含1%生物类黄酮可以显著减少皮肤油脂分泌达21%,复配了肌氨酸和狗牙蔷薇果提取物可以显著减少皮肤油脂分泌达38%,复配了肌氨酸和狗牙蔷薇果提取物具有显著增强生物类黄酮控油效果的作用。
实施例2
同实施例1,按照表3所示的配方配制含植物活性成分的控油组合物,只是以控油组合物总重量计,构棘(Maclura cochinchinensis)叶提取物占0.3%,狗牙蔷薇(Rosacanina L.)果提取物占2%,肌氨酸占0.2%。
实施例3
同实施例1,按照表3所示的配方配制含植物活性成分的控油组合物,只是以控油组合物总重量计,构棘(Maclura cochinchinensis)叶提取物占0.8%,狗牙蔷薇(Rosacanina L.)果提取物占1.2%,肌氨酸占0.02%。
实施例4
同实施例1,按照表3所示的配方配制含植物活性成分的控油组合物,只是以控油组合物总重量计,构棘(Maclura cochinchinensis)叶提取物占2%,狗牙蔷薇(Rosacanina L.)果提取物占0.2%,肌氨酸占0.02%。
实施例5
同实施例1,按照表3所示的配方配制含植物活性成分的控油组合物,只是以控油组合物总重量计,构棘(Maclura cochinchinensis)叶提取物占0.1%,狗牙蔷薇(Rosacanina L.)果提取物占3%,肌氨酸占0.2%。
实施例6
同实施例1,按照表3所示的配方配制含植物活性成分的控油组合物,只是以控油组合物总重量计,构棘(Maclura cochinchinensis)叶提取物占5%,狗牙蔷薇(Rosacanina L.)果提取物占0.3%,肌氨酸占0.02%。
Claims (10)
1.一种含植物活性成分的控油组合物,该控油组合物包含基础液和抑制5α-还原酶的成分,其中,所述的抑制5α-还原酶的成分包括生物类黄酮。
2.如权利要求1所述的控油组合物,其中,所述的生物类黄酮是植物构棘(Macluracochinchinensis)叶提取物。
3.如权利要求2所述的控油组合物,其中,以重量百分比计,所述的构棘(Macluracochinchinensis)叶提取物占所述控油组合物总重量的0.1-10%。
4.如权利要求1-3之一所述的控油组合物,其中,所述的控油组合物中还包含抑制皮脂腺细胞分化的成分。
5.如权利要求4所述的控油组合物,其中,所述的抑制皮脂腺细胞分化的成分为狗牙蔷薇(Rosa canina L.)果提取物。
6.如权利要求5所述的控油组合物,其中,以重量百分比计,所述的狗牙蔷薇(Rosacanina L.)果提取物占所述控油组合物总重量的0.1-5%。
7.如权利要求5所述的控油组合物,其中,所述的控油组合物进一步含有肌氨酸。
8.如权利要求7所述的控油组合物,其中,以重量百分比计,所述的肌氨酸占所述控油组合物总重量的0.01-1%。
9.如权利要求8所述的控油组合物,其中,其中,以重量百分比计,所述的构棘(Macluracochinchinensis)叶提取物、狗牙蔷薇(Rosa canina L.)果提取物和肌氨酸分别占所述控油组合物总重量的0.1-10%、0.1-5%和0.02-1%。
10.如权利要求9所述的控油组合物,其中,其中,以重量百分比计,所述的构棘(Maclura cochinchinensis)叶提取物、狗牙蔷薇(Rosa canina L.)果提取物和肌氨酸分别占所述控油组合物总重量的0.3-3%、0.2-2%和0.02-0.2%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110940452.8A CN113425650A (zh) | 2021-08-16 | 2021-08-16 | 一种含植物活性成分的控油组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110940452.8A CN113425650A (zh) | 2021-08-16 | 2021-08-16 | 一种含植物活性成分的控油组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113425650A true CN113425650A (zh) | 2021-09-24 |
Family
ID=77797685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110940452.8A Pending CN113425650A (zh) | 2021-08-16 | 2021-08-16 | 一种含植物活性成分的控油组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113425650A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115670952A (zh) * | 2022-11-11 | 2023-02-03 | 深圳八零赞电子商务有限公司 | 一种控油抗痘的组合物、护肤品及制备方法 |
CN116492238A (zh) * | 2023-04-23 | 2023-07-28 | 广州集妍化妆品科技有限公司 | 预防和治疗痤疮的组合物及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3040105A1 (fr) * | 2015-01-05 | 2016-07-06 | Societe Industrielle Limousine d'Application Biologique | Utilisation cosmetique d'un extrait de baies de rosa canina particulier comme actif anti-seborrhee |
CN107126379A (zh) * | 2017-05-16 | 2017-09-05 | 湖南御家化妆品制造有限公司 | 控油祛痘组合物及其应用 |
CN111643425A (zh) * | 2020-06-29 | 2020-09-11 | 广州广妆生物科技有限公司 | 一种纯天然植物控油收敛组合物、精华液及其制备方法 |
CN111991303A (zh) * | 2020-09-27 | 2020-11-27 | 广州德谷个人护理用品有限公司 | 一种具有多靶点头皮控油去屑功效的植物提取物组合物、其制备方法及头皮护理组合物 |
-
2021
- 2021-08-16 CN CN202110940452.8A patent/CN113425650A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3040105A1 (fr) * | 2015-01-05 | 2016-07-06 | Societe Industrielle Limousine d'Application Biologique | Utilisation cosmetique d'un extrait de baies de rosa canina particulier comme actif anti-seborrhee |
CN107126379A (zh) * | 2017-05-16 | 2017-09-05 | 湖南御家化妆品制造有限公司 | 控油祛痘组合物及其应用 |
CN111643425A (zh) * | 2020-06-29 | 2020-09-11 | 广州广妆生物科技有限公司 | 一种纯天然植物控油收敛组合物、精华液及其制备方法 |
CN111991303A (zh) * | 2020-09-27 | 2020-11-27 | 广州德谷个人护理用品有限公司 | 一种具有多靶点头皮控油去屑功效的植物提取物组合物、其制备方法及头皮护理组合物 |
Non-Patent Citations (3)
Title |
---|
海淘族: "肌氨酸在护肤化妆品中的功效与作用", 《百度HTTPS://WWW.KQMMM.COM/COSMETIC/202545.HTML》 * |
薄荷酱小Q: "Peter Thomas Roth Acne-Clear无油祛痘乳液", <微博HTTPS://M.WEIBO.CN/STATUS/4580229102705961> * |
赵运林等: "《湖南药用植物资源》", 30 June 2009 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115670952A (zh) * | 2022-11-11 | 2023-02-03 | 深圳八零赞电子商务有限公司 | 一种控油抗痘的组合物、护肤品及制备方法 |
CN115670952B (zh) * | 2022-11-11 | 2024-03-19 | 深圳八零赞电子商务有限公司 | 一种控油抗痘的组合物、护肤品及制备方法 |
CN116492238A (zh) * | 2023-04-23 | 2023-07-28 | 广州集妍化妆品科技有限公司 | 预防和治疗痤疮的组合物及其应用 |
CN116492238B (zh) * | 2023-04-23 | 2024-07-30 | 广州集妍化妆品科技有限公司 | 预防和治疗痤疮的组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4144344A1 (en) | Biomimetic and camellia extract-containing skin barrier repair composition and application thereof | |
CA2611374C (en) | A cosmetic composition and a process for preparing said composition | |
CN112263524A (zh) | 一种具有多重护肤功效的化妆品组合物及其制备方法 | |
CN110638709A (zh) | 一种抗蓝光的多效修护眼霜及其制备方法 | |
CN109394585B (zh) | 一种抗氧化和保湿液晶组合物及其制备方法和应用 | |
CN112107506B (zh) | 视黄醇类包裹物及其制备方法和应用 | |
CN111840161A (zh) | 一种抗衰提亮组合物及其应用和制备方法 | |
CN112641694B (zh) | 一种美白精华乳及其制备方法 | |
CN113712873B (zh) | 一种具有祛痘抗炎功效的精华乳组合物及其制备方法 | |
CN111053728B (zh) | 一种调节肌肤水油平衡的组合物及其化妆品 | |
CN113425650A (zh) | 一种含植物活性成分的控油组合物 | |
CN113768809B (zh) | 一种具有温和去角质功效的组合物及其制备方法与应用 | |
EP2042159B1 (en) | Agent for improving fine wrinkles | |
WO2021208410A1 (zh) | 一种美白紧肤润肤面霜及制备方法 | |
KR20030052019A (ko) | 주름개선 활성물질을 함유하는 분말형 화장료 조성물 | |
JP7016500B1 (ja) | 防水アイペンシル化粧品組成物及びこれを用いる防水アイペンシル化粧品の製造方法 | |
CN116966124A (zh) | 一种防水防汗持妆养肤粉底液及其制备方法 | |
EP3620213B1 (en) | Retinol oil composition | |
CN111728912A (zh) | 一种保湿舒敏素颜霜及其制备方法 | |
CN107496286B (zh) | 一种淡化细纹补水滋润型水乳及其制备方法 | |
CN115778870A (zh) | 一种抗皱抗衰老的组合物及其制备方法和应用 | |
WO2022223000A1 (zh) | 保湿组合物、皮肤修护特护霜、粉底组合物及其制备方法 | |
CN112220724A (zh) | 一种植物组合物及其制备方法与应用 | |
CN115581626B (zh) | 一种保湿、抗氧化、舒缓组合物及其应用 | |
CN116139050B (zh) | 一种微囊包覆沙棘籽油和葡萄籽油的精华水及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210924 |